Structural cardiac disease has become an intensive field of medical device development. Using the interventional suite described above, we perform TAVI, mitral valve replacement (with transapical or transeptal approaches), LAA occlusion, PFO occlusion on a regular basis.
A magnetic resonance imaging (MRI) scanner (1.5 tesla Magnetom Sonata, Siemens), hybrid surgical room with computer tomography (CT) scanner (Somatom Sensation 16, Siemens) and an Intra-Cardiac Echography (ICE) (Acuson, Siemens) are also available on-site to complement and support these studies.
With the support of its Regenerative Medicine Laboratories, AccelLAB is also very active in the study of various treatment modalities for myocardial infarct whether it be with cell therapy or local drug delivery. AccelLAB’s surgeons are experienced in both surgical and endovascular approaches.